Alzheimer’s Disease Treatment Market Growth Outlook Through 2024-2033 | Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company

Overview and Scope
Alzheimer’s disease treatment refers to a medication designed and developed to treat Alzheimer’s. This treatment, which targets the protein beta-amyloid and is an immunotherapy, aids in the reduction of amyloid plaques, which are brain lesions connected to Alzheimer’s disease. The progression of this disease causes severe memory impairment, and the person may lose the ability to carry out everyday tasks.

Sizing and Forecast
The alzheimer’s disease treatment market size has grown strongly in recent years. It will grow from $5.93 billion in 2023 to $6.41 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%.  The  growth in the historic period can be attributed to advancements in research and understanding, drug approvals and market entry, government initiatives and funding, public awareness and education.

The alzheimer’s disease treatment market size is expected to see strong growth in the next few years. It will grow to $8.35 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%.  The growth in the forecast period can be attributed to precision medicine approaches, rising healthcare expenditure, global burden of disease, genetic and biomarker research, emerging markets. Major trends in the forecast period include biotechnological breakthroughs, technological innovations, digital health technologies, precision medicine approaches, neuroinflammation modulation, collaborations and partnerships.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report

Segmentation & Regional Insights
The alzheimer’s disease treatment market covered in this report is segmented –

1) By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins
2) By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists
3) By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics

North America is the largest region in the alzheimer’s disease treatment market in 2023. Middle East is expected to be the fastest growing region in the alzheimer’s disease treatment market share during the forecast period. The regions covered in the alzheimer’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3409&type=smp

Major Driver Impacting Market Growth
The increasing cases of Alzheimer’s are a major factor contributing to the growth of the alzheimer’s disease treatment market. Alzheimer’s is the most common type of dementia. The USA Alzheimer’s Association expects that all the states in the US are projected to face a rise of at least 14% in the number of Alzheimer’s patients by 2025 due to the increase in the geriatric population. At the global level, the estimated new cases of Alzheimer’s are expected to grow by 35% to 615,000 by 2030, and by 110% to 959,000 by 2050. Therefore, the increasing prevalence of alzheimer’s disease is expected to drive the demand of the growth of global alzheimer’s disease treatment market.

Key Industry Players
Major companies operating in the alzheimer’s disease treatment market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Merck Sharp & Dohme Corp., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., UCB S.A., Eisai Co. Ltd., Forest Laboratories LLC, Ono Pharmaceutical Co. Ltd., H. Lundbeck A/S, Allergan plc, Merz Pharma GmbH & Co. KGaA, Luye Pharma Group, Avanir Pharmaceuticals Inc., Denali Therapeutics Inc., Athira Pharma Inc., ProMIS Neurosciences Inc., AC Immune SA, vTv Therapeutics Inc., AB Science SA, TauRx Pharmaceuticals Ltd., Alzheon Inc.

The alzheimer’s disease treatment market report table of contents includes:
Table Of Contents
1. Executive Summary
2. Alzheimer’s Disease Treatment Market Characteristics
3. Alzheimer’s Disease Treatment Market Trends And Strategies
4. Alzheimer’s Disease Treatment Market – Macro Economic Scenario
5. Global Alzheimer’s Disease Treatment Market Size and Growth
…………….
32. Global Alzheimer’s Disease Treatment Market Competitive Benchmarking
33. Global Alzheimer’s Disease Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Alzheimer’s Disease Treatment Market
35. Alzheimer’s Disease Treatment Market Future Outlook and Potential Analysis
36. Appendix

Explore the trending research reports from TBRC:
https://topprnews.com/surge-arrester-market-forecast/
https://topprnews.com/surgical-retractors-market-outlook/
https://topprnews.com/sweet-potatoes-market-forecast/
https://goodprnews.com/surge-arrester-market-research/
https://goodprnews.com/surgical-retractors-market-growth/
https://goodprnews.com/sweet-potatoes-market-trends/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model